Job Kurian And Athira Interviewing
00 per share, generating gross proceeds of $204. 0 million before deducting underwriting discounts and commissions and estimated offering expenses. In October 2020, Athira sold an additional 1, 397, 712 shares of common stock to the underwriters of the IPO upon partial exercise of the underwriters' option to purchase additional shares at the initial public offering price, resulting in gross proceeds of approximately $23. 8 million before deducting underwriting discounts and commissions and estimated offering expenses. Third Quarter 2020 Financial Results Liquidity Position. Cash, cash equivalents and investments were $259. 9 million as of September 30, 2020, as compared to $85. 2 million as of June 30, 2020. Research and Development (R&D) Expenses. R&D expenses were $5. 8 million for the quarter ended September 30, 2020, as compared to $1. 0 million for the same period in 2019. The increase was driven primarily by start-up activities by our clinical research organization and clinical drug supply manufacturers for Phase 2 Alzheimer's clinical trials of ATH-1017.
Mithra Kurian Interview
- Mithra Kurian Interview
- Wiki jobs grant thornton phone interview
- Job Opportunities - Town of West Hartford
- Daily express sabah job vacancy 2016 malaysia latest
- Job roles of a prison officer vacances particulier
- Athira Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights
- Rajasthan education department vacancy job openings
- Go Jamaica - JobSmart : Jamaican Jobs and Careers News
- Current Openings at Springfield Prep — Springfield Prep Charter School
- Jobs in Mbarara, 115+ Vacancies, Offers - March 2021 | Alljobspo.com
- Top Jobs in Sutton, Alaska - Apply Today | Resume.com
These forward-looking statements speak only as of the date hereof and Athira undertakes no obligation to update forward-looking statements. Athira may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements, and you should not place undue reliance on the forward-looking statements. "Athira, " "Athira Pharma" and the Athira logo are registered trademarks or trademarks of Athira Pharma, Inc. in various jurisdictions. All other trademarks belong to their respective owner.
General and Administrative (G&A) Expenses. G&A expenses were $1. 6 million for the quarter ended September 30, 2020, as compared to $0. 5 million for the same period in 2019. The increase was primarily due to legal, accounting, technical and consulting services and personnel-related costs to support the increase in clinical activities. Net Loss. Net loss was $8. 5 million, or $1. 12 loss per share, for the quarter ended September 30, 2020, as compared to $1. 5 million or $0. 43 loss per share, for the same period in 2019. About Athira Pharma, Inc. Athira, headquartered in Seattle, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. We aim to provide rapid cognitive improvement and alter the course of neurological diseases with our novel mechanism of action. Athira is currently advancing its lead therapeutic candidate, ATH-1017, a novel small molecule for Alzheimer's and Parkinson's dementia. For more information, visit.
Famous Singer Job Kurian and his lovely wife Athira Job chat with Nandini Nair in Hello Namasthey Episode - 2 This is a popular video chat show in Mazhavil Manorama. Director: Parvathy Anchor: Nandini Nair Видео Hello Namasthey Episode - 2 Job Kurian, Athira Job chat with Nandini Nair канала Hello Namasthey Показать